- Brand name:
- Pharmaceutical Company:
- Condition/Indication: Opioid dependence
- Meeting Date: June 2025
- Public Summary Document (PSD) July 2023 PBAC Out-of-Session Meeting - (PDF 450KB)
- Public Summary Document (PSD) July 2023 PBAC Out-of-Session Meeting - (Word 60KB)
Interim Report of the Post-market Review of Opioid Dependence Treatment Program medicines – OOS 2023
Interim Report of the Post-market Review of Opioid Dependence Treatment Program medicines – OOS 2023
Last updated
7 July 2025